瑞普生物：8月22日召开董事会会议

Group 1 - The core viewpoint of the article is that Reap Bio (SZ 300119) held its 26th meeting of the fifth board of directors on August 22, 2025, to review the agenda including the "2025 Semi-Annual Report" and its summary [1] - For the year 2024, the revenue composition of Reap Bio is as follows: 43.12% from veterinary biological products, 33.86% from veterinary drugs, 20.63% from pet supply chain, and 2.38% from other sources [1]